Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Serum and Synovial Uric Acid Validated as Markers for Osteoarthritis

By LabMedica International staff writers
Posted on 02 Feb 2011
The amount of uric acid in the synovial fluid of the knee is strongly correlated with the severity of osteoarthritis and the progression of the disease over time. More...


The amount of uric acid in both serum and synovial fluid can be estimated using high performance liquid chromatography (HPLC) and correlated with the severity of debilitating joint degeneration found in patients with osteoarthritis (OA).

A study carried out at Duke University Medical Center (Durham, NC, USA) examined 159 (118 females, 41 males) patients, who had knee osteoarthritis but no history of gout, a type of arthritis triggered by uric acid crystals in the joints. A total of 138 participants returned for follow-up three years later to assess progression of knee OA. The study was conducted from January 2003 until March 2008. Serum and knee synovial fluid samples were obtained within 10 minutes of each other after a two hour fast in the mid-afternoon. The synovial fluid analyses were limited to 69 study participants (49 women and 20 men) with sufficient synovial fluid volumes for uric acid analyses.

Although this cohort was recruited based on knee OA and absence of gout history, a surprising 39% of this cohort had serum uric acid concentrations above their respective reference ranges of 7.2 mg/dL for men and 6.0 mg/dL for women. Uric acid was quantified in both knees of 63 participants and single knees of 6 participants, and their paired sera. The mean serum uric acid concentrations were significantly higher than their paired synovial fluid uric acid concentrations. Of the 132 synovial fluid samples, matched serum exceeded synovial fluid uric acid concentrations for 113 (85.6%), whereas only 19 (14.4%) had greater synovial fluid than serum uric acid concentrations.

Virginia Byers Kraus, MD, PhD, professor of medicine at Duke University, said, "We've always thought of uric acid as the agent for gout, but it may be a much more general agent. In a non-gout population, this provides some of the very first evidence that uric acid level is a potential cause of inflammatory events and joint degeneration in osteoarthritis.” The study was accepted for publication on December 10, 2010, in the Proceeding of the [US] National Academy of Science of the United States, (PNAS).

Related Links:

Duke University Medical Center




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.